Mangoceuticals

Mangoceuticals Book Value per Share

The Book Value per Share of Mangoceuticals (MGRX) as of Nov 5, 2026 is 0.99 USD. In the previous year, Book Value per Share was 0.91 USD — a change of 8.99% (higher).

Book Value per Share

0.99USD

YoY

8.99%

Last updated:

Book Value per Share of Mangoceuticals is 2025 0.99 USD. Book Value per Share of Mangoceuticals was 2024 0.91 USD. It decreases by 8.99% higher compared to the previous year.

The Mangoceuticals Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2021
-0.00 USD
Jan 1, 2022
0.04 USD
Jan 1, 2023
0.05 USD
Jan 1, 2024
0.91 USD
Jan 1, 2025
0.99 USD
The Mangoceuticals Book Value per Share history
YEARBook Value per ShareYoY
0.99USD+8.99%
0.91USD+1,700.07%
0.05USD+26.18%
0.04USD-3,772.43%
-0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mangoceuticals Stock analysis

What does Mangoceuticals do? Mangoceuticals, Inc. generates revenue through its telemedicine platform by developing, marketing, and selling men’s wellness products, primarily the Mango ED product. The Mango ED product, available in two formulations with Tadalafil (10mg or 20mg) combined with Oxytocin (100IU) and L-Arginine (50mg), is marketed via the company's telehealth service. Customers access licensed healthcare professionals through MangoRX.com, receive prescriptions, and purchase the product through a partnered pharmacy for online fulfillment. The company targets men seeking ED solutions through a digital health platform, leveraging telemedicine to connect users with healthcare providers and facilitate medication distribution. The firm’s primary product, Mango ED, is sold through its telehealth platform, which integrates consultations with licensed professionals and pharmacy services. Consumers use the MangoRX.com portal to engage with healthcare providers, obtain prescriptions, and receive the Mango ED product via online pharmacy delivery. The company focuses on the men’s wellness market, specifically addressing erectile dysfunction with its branded medication, and monetizes through the sale of these products and associated telehealth services. Mangoceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mangoceuticals stock

Book Value per Share of Mangoceuticals is 0.99 USD in 2025.

Book Value per Share of Mangoceuticals changed from 0.91 USD to 0.99 USD, representing a 8.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Mangoceuticals since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Mangoceuticals

All Key Metrics — Mangoceuticals